Professor Jean-Francois Korobelnik, University Hospital of Bordeaux, France
Advertisement
Articles by Professor Jean-Francois Korobelnik, University Hospital of Bordeaux, France
Advertisement
Latest Updated Articles
- EYLEA’s unique MoA: What is the rationale for the higher molar dose?
Published: January 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
Q&A: Evolving approaches to geographic atrophy management
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
5